<DrugInformationSummary id="CDR0000557341"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Raloxifene is a type of hormone therapy called a selective estrogen receptor modulator (or SERM). It works by binding to estrogen receptors, blocking estrogen’s effects in some tissues while mimicking its effects in others. In breast tissue, raloxifene blocks estrogen from binding to its receptors, which may prevent the growth of cancer cells. Raloxifene mimics estrogen’s effects in bone tissue, which may reduce bone resorption and turnover and increase bone mineral density.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/raloxifenehydrochloride">Raloxifene Hydrochloride</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000043109">raloxifene hydrochloride</TerminologyLink><GlossaryLink ref="CDR0000572250">raloxifene hydrochloride</GlossaryLink><USBrandNames><USBrandName>Evista</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>ra-LOK-sih-feen HY-droh-KLOR-ide</TermPronunciation><MediaLink ref="CDR0000720793" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000720792" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=RALOXIFENE+HYDROCHLORIDE&amp;pagesize=20&amp;page=2&amp;audience=consumer&amp;vfile=">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Raloxifene Hydrochloride</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=RALOXIFENE+HYDROCHLORIDE&amp;pagesize=20&amp;page=2&amp;audience=consumer&amp;vfile=">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Raloxifene hydrochloride is approved to <GlossaryTermRef href="CDR0000439419" dictionary="Cancer.gov" audience="Patient">prevent</GlossaryTermRef>:</Para>                          
 <ItemizedList Style="bullet" id="_7"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef>.</Strong> It is used to lower the risk of <GlossaryTermRef href="CDR0000537695" dictionary="Cancer.gov" audience="Patient">invasive breast cancer</GlossaryTermRef> in <GlossaryTermRef href="CDR0000045269" dictionary="Cancer.gov" audience="Patient">postmenopausal</GlossaryTermRef> women who  have <GlossaryTermRef href="CDR0000045371" dictionary="Cancer.gov" audience="Patient">osteoporosis</GlossaryTermRef> or a high risk of developing invasive breast cancer.</ListItem></ItemizedList><Para id="_6">Raloxifene hydrochloride is also approved to  prevent and treat:</Para><ItemizedList Style="bullet" id="_8"><ListItem><Strong>Osteoporosis</Strong> in postmenopausal women.</ListItem></ItemizedList><Para id="_9">Raloxifene hydrochloride is also being studied in the treatment of other types of cancer.</Para></Section><Section id="_About"><Title>More About Raloxifene Hydrochloride</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/43109">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.28">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a698007.html">Raloxifene Hydrochloride</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.29"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.30">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet">Hormone Therapy for Breast Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C1762">Find Clinical Trials for Raloxifene Hydrochloride</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2007-10-26</DateFirstPublished><DateLastModified>2025-01-02</DateLastModified></DrugInformationSummary>
